At the end of May 2020, Kumovis, a 3D printing company in Munich, Germany, announced that it has completed a round of financing of 3.6 million euros.
In this round of financing, a total of three seed investors, including High-Tech Gründerfonds and Ffilipa Venture Capital, together with Solvay Ventures and Renolit SE, provide financial support for the German OEM.
Antarctic Bear learned that Kumovis launched the R1 3D printing system based on FDM extrusion in August 2019, which is mainly aimed at the medical industry and is also suitable for more industrial environments. It is reported that the machine is equipped with a patented temperature management system, the construction room temperature reaches 250 ℃, the filter system can ensure the integration of the clean room, prevent defects in printed parts, and open to third-party materials.
Kumovis has established a cooperative relationship with the software company Hyperganic. It already has many early customers, and also works closely with medical device manufacturers to develop applications. They believe that its cooperation with medical company Renolit and materials expert Solvay is the key to its future success in the medical industry.
"We believe that cooperation with Renolit, a leader in the field of polymer medical device components, and Solvay, a global leader in high-performance specialty polymers, will strengthen our business strength and accelerate Kumovis' long-term development." Kumovis Co-CEO Official and co-founder Stefan Leonhardt commented. "We will use this investment to enter new markets, further develop our technology, and help the medical community bring 3D printed medical products to patients."
"With its impressive team, impressive product quality and performance attributes, we believe that Kumovis is expected to disrupt traditional production methods in the demanding medical industry," said Thomas Sampers of Renolit Healthcare. "By accelerating the transition to personalized medicine, Kumovis and Solvay will jointly expand the application space of high-performance specialty polymers in the field of healthcare, and may also have potential in other industries. The investment is Renolit Healthcare An important step in medical care, by strengthening its influence in the field of polymer medical equipment, and working with partners to cultivate its innovation momentum in the health field. "